A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study To Evaluate the Safety And Efficacy Of Prolonged Release OROS Methylphenidate Hydrochloride (18, 36 and 72 mg/Day), With Open-Label Extension, In Adults With Attention Deficit/Hyperactivity Disorder
收藏DataCite Commons2025-01-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004666/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the effectiveness and safety of three doses of prolonged-release methylphenidate (a central nervous system (CNS) stimulant) in adult patients with attention deficit/hyperactivity disorder (ADHD).
提供机构：
Vivli
创建时间：
2019-09-19
